Clinical, biochemical and molecular features of Iranian families with mucopolysaccharidosis: A case series
This study aims to ascertain the genetic variants which contribute to the most common types of MPS in eleven Iranian families. Clinical and biochemical features were obtained during initial examination and patients were further investigated for genetic defects in the MPS genes. Peripheral blood samp...
Ausführliche Beschreibung
Autor*in: |
Yassaee, Vahid Reza [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2017transfer abstract |
---|
Umfang: |
8 |
---|
Übergeordnetes Werk: |
Enthalten in: Li-CO - Zhang, Peng-Fang ELSEVIER, 2022, international journal of clinical chemistry and applied molecular biology, Amsterdam [u.a.] |
---|---|
Übergeordnetes Werk: |
volume:474 ; year:2017 ; pages:88-95 ; extent:8 |
Links: |
---|
DOI / URN: |
10.1016/j.cca.2017.08.017 |
---|
Katalog-ID: |
ELV020534698 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | ELV020534698 | ||
003 | DE-627 | ||
005 | 20230625132026.0 | ||
007 | cr uuu---uuuuu | ||
008 | 180603s2017 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.cca.2017.08.017 |2 doi | |
028 | 5 | 2 | |a GBV00000000000002.pica |
035 | |a (DE-627)ELV020534698 | ||
035 | |a (ELSEVIER)S0009-8981(17)30319-4 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | |a 540 |a 610 | |
082 | 0 | 4 | |a 540 |q DE-600 |
082 | 0 | 4 | |a 610 |q DE-600 |
082 | 0 | 4 | |a 660 |q VZ |
082 | 0 | 4 | |a 660 |q VZ |
084 | |a 58.10 |2 bkl | ||
100 | 1 | |a Yassaee, Vahid Reza |e verfasserin |4 aut | |
245 | 1 | 0 | |a Clinical, biochemical and molecular features of Iranian families with mucopolysaccharidosis: A case series |
264 | 1 | |c 2017transfer abstract | |
300 | |a 8 | ||
336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
337 | |a nicht spezifiziert |b z |2 rdamedia | ||
338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
520 | |a This study aims to ascertain the genetic variants which contribute to the most common types of MPS in eleven Iranian families. Clinical and biochemical features were obtained during initial examination and patients were further investigated for genetic defects in the MPS genes. Peripheral blood samples were obtained from all family members after obtaining written informed consent. Based on the patient's clinical diagnosis, three different genetic tests including Sanger sequencing of four genes (IDUA, IDS, SGSH, and GALNS), targeted panel (10 genes) and Whole Exome Sequencing (WES) techniques were applied to identify the causative variants. A total of 12 different mutations were identified in five genes, including nine novel mutations and three previously reported missense mutations. Sanger sequencing confirmation of the identified mutations determined one case of compound heterozygous in the NAGLU gene. | ||
520 | |a This study aims to ascertain the genetic variants which contribute to the most common types of MPS in eleven Iranian families. Clinical and biochemical features were obtained during initial examination and patients were further investigated for genetic defects in the MPS genes. Peripheral blood samples were obtained from all family members after obtaining written informed consent. Based on the patient's clinical diagnosis, three different genetic tests including Sanger sequencing of four genes (IDUA, IDS, SGSH, and GALNS), targeted panel (10 genes) and Whole Exome Sequencing (WES) techniques were applied to identify the causative variants. A total of 12 different mutations were identified in five genes, including nine novel mutations and three previously reported missense mutations. Sanger sequencing confirmation of the identified mutations determined one case of compound heterozygous in the NAGLU gene. | ||
700 | 1 | |a Hashemi-Gorji, Feyzollah |4 oth | |
700 | 1 | |a Miryounesi, Mohammad |4 oth | |
700 | 1 | |a Rezayi, Alireza |4 oth | |
700 | 1 | |a Ravesh, Zeinab |4 oth | |
700 | 1 | |a Yassaee, Fakhrolmolouk |4 oth | |
700 | 1 | |a Salehpour, Shadab |4 oth | |
773 | 0 | 8 | |i Enthalten in |n Elsevier Science |a Zhang, Peng-Fang ELSEVIER |t Li-CO |d 2022 |d international journal of clinical chemistry and applied molecular biology |g Amsterdam [u.a.] |w (DE-627)ELV008356149 |
773 | 1 | 8 | |g volume:474 |g year:2017 |g pages:88-95 |g extent:8 |
856 | 4 | 0 | |u https://doi.org/10.1016/j.cca.2017.08.017 |3 Volltext |
912 | |a GBV_USEFLAG_U | ||
912 | |a GBV_ELV | ||
912 | |a SYSFLAG_U | ||
912 | |a SSG-OLC-PHA | ||
936 | b | k | |a 58.10 |j Verfahrenstechnik: Allgemeines |q VZ |
951 | |a AR | ||
952 | |d 474 |j 2017 |h 88-95 |g 8 | ||
953 | |2 045F |a 540 |
author_variant |
v r y vr vry |
---|---|
matchkey_str |
yassaeevahidrezahashemigorjifeyzollahmir:2017----:lncliceiaadoeuafaueoiainaiisihuooy |
hierarchy_sort_str |
2017transfer abstract |
bklnumber |
58.10 |
publishDate |
2017 |
allfields |
10.1016/j.cca.2017.08.017 doi GBV00000000000002.pica (DE-627)ELV020534698 (ELSEVIER)S0009-8981(17)30319-4 DE-627 ger DE-627 rakwb eng 540 610 540 DE-600 610 DE-600 660 VZ 660 VZ 58.10 bkl Yassaee, Vahid Reza verfasserin aut Clinical, biochemical and molecular features of Iranian families with mucopolysaccharidosis: A case series 2017transfer abstract 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier This study aims to ascertain the genetic variants which contribute to the most common types of MPS in eleven Iranian families. Clinical and biochemical features were obtained during initial examination and patients were further investigated for genetic defects in the MPS genes. Peripheral blood samples were obtained from all family members after obtaining written informed consent. Based on the patient's clinical diagnosis, three different genetic tests including Sanger sequencing of four genes (IDUA, IDS, SGSH, and GALNS), targeted panel (10 genes) and Whole Exome Sequencing (WES) techniques were applied to identify the causative variants. A total of 12 different mutations were identified in five genes, including nine novel mutations and three previously reported missense mutations. Sanger sequencing confirmation of the identified mutations determined one case of compound heterozygous in the NAGLU gene. This study aims to ascertain the genetic variants which contribute to the most common types of MPS in eleven Iranian families. Clinical and biochemical features were obtained during initial examination and patients were further investigated for genetic defects in the MPS genes. Peripheral blood samples were obtained from all family members after obtaining written informed consent. Based on the patient's clinical diagnosis, three different genetic tests including Sanger sequencing of four genes (IDUA, IDS, SGSH, and GALNS), targeted panel (10 genes) and Whole Exome Sequencing (WES) techniques were applied to identify the causative variants. A total of 12 different mutations were identified in five genes, including nine novel mutations and three previously reported missense mutations. Sanger sequencing confirmation of the identified mutations determined one case of compound heterozygous in the NAGLU gene. Hashemi-Gorji, Feyzollah oth Miryounesi, Mohammad oth Rezayi, Alireza oth Ravesh, Zeinab oth Yassaee, Fakhrolmolouk oth Salehpour, Shadab oth Enthalten in Elsevier Science Zhang, Peng-Fang ELSEVIER Li-CO 2022 international journal of clinical chemistry and applied molecular biology Amsterdam [u.a.] (DE-627)ELV008356149 volume:474 year:2017 pages:88-95 extent:8 https://doi.org/10.1016/j.cca.2017.08.017 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 58.10 Verfahrenstechnik: Allgemeines VZ AR 474 2017 88-95 8 045F 540 |
spelling |
10.1016/j.cca.2017.08.017 doi GBV00000000000002.pica (DE-627)ELV020534698 (ELSEVIER)S0009-8981(17)30319-4 DE-627 ger DE-627 rakwb eng 540 610 540 DE-600 610 DE-600 660 VZ 660 VZ 58.10 bkl Yassaee, Vahid Reza verfasserin aut Clinical, biochemical and molecular features of Iranian families with mucopolysaccharidosis: A case series 2017transfer abstract 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier This study aims to ascertain the genetic variants which contribute to the most common types of MPS in eleven Iranian families. Clinical and biochemical features were obtained during initial examination and patients were further investigated for genetic defects in the MPS genes. Peripheral blood samples were obtained from all family members after obtaining written informed consent. Based on the patient's clinical diagnosis, three different genetic tests including Sanger sequencing of four genes (IDUA, IDS, SGSH, and GALNS), targeted panel (10 genes) and Whole Exome Sequencing (WES) techniques were applied to identify the causative variants. A total of 12 different mutations were identified in five genes, including nine novel mutations and three previously reported missense mutations. Sanger sequencing confirmation of the identified mutations determined one case of compound heterozygous in the NAGLU gene. This study aims to ascertain the genetic variants which contribute to the most common types of MPS in eleven Iranian families. Clinical and biochemical features were obtained during initial examination and patients were further investigated for genetic defects in the MPS genes. Peripheral blood samples were obtained from all family members after obtaining written informed consent. Based on the patient's clinical diagnosis, three different genetic tests including Sanger sequencing of four genes (IDUA, IDS, SGSH, and GALNS), targeted panel (10 genes) and Whole Exome Sequencing (WES) techniques were applied to identify the causative variants. A total of 12 different mutations were identified in five genes, including nine novel mutations and three previously reported missense mutations. Sanger sequencing confirmation of the identified mutations determined one case of compound heterozygous in the NAGLU gene. Hashemi-Gorji, Feyzollah oth Miryounesi, Mohammad oth Rezayi, Alireza oth Ravesh, Zeinab oth Yassaee, Fakhrolmolouk oth Salehpour, Shadab oth Enthalten in Elsevier Science Zhang, Peng-Fang ELSEVIER Li-CO 2022 international journal of clinical chemistry and applied molecular biology Amsterdam [u.a.] (DE-627)ELV008356149 volume:474 year:2017 pages:88-95 extent:8 https://doi.org/10.1016/j.cca.2017.08.017 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 58.10 Verfahrenstechnik: Allgemeines VZ AR 474 2017 88-95 8 045F 540 |
allfields_unstemmed |
10.1016/j.cca.2017.08.017 doi GBV00000000000002.pica (DE-627)ELV020534698 (ELSEVIER)S0009-8981(17)30319-4 DE-627 ger DE-627 rakwb eng 540 610 540 DE-600 610 DE-600 660 VZ 660 VZ 58.10 bkl Yassaee, Vahid Reza verfasserin aut Clinical, biochemical and molecular features of Iranian families with mucopolysaccharidosis: A case series 2017transfer abstract 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier This study aims to ascertain the genetic variants which contribute to the most common types of MPS in eleven Iranian families. Clinical and biochemical features were obtained during initial examination and patients were further investigated for genetic defects in the MPS genes. Peripheral blood samples were obtained from all family members after obtaining written informed consent. Based on the patient's clinical diagnosis, three different genetic tests including Sanger sequencing of four genes (IDUA, IDS, SGSH, and GALNS), targeted panel (10 genes) and Whole Exome Sequencing (WES) techniques were applied to identify the causative variants. A total of 12 different mutations were identified in five genes, including nine novel mutations and three previously reported missense mutations. Sanger sequencing confirmation of the identified mutations determined one case of compound heterozygous in the NAGLU gene. This study aims to ascertain the genetic variants which contribute to the most common types of MPS in eleven Iranian families. Clinical and biochemical features were obtained during initial examination and patients were further investigated for genetic defects in the MPS genes. Peripheral blood samples were obtained from all family members after obtaining written informed consent. Based on the patient's clinical diagnosis, three different genetic tests including Sanger sequencing of four genes (IDUA, IDS, SGSH, and GALNS), targeted panel (10 genes) and Whole Exome Sequencing (WES) techniques were applied to identify the causative variants. A total of 12 different mutations were identified in five genes, including nine novel mutations and three previously reported missense mutations. Sanger sequencing confirmation of the identified mutations determined one case of compound heterozygous in the NAGLU gene. Hashemi-Gorji, Feyzollah oth Miryounesi, Mohammad oth Rezayi, Alireza oth Ravesh, Zeinab oth Yassaee, Fakhrolmolouk oth Salehpour, Shadab oth Enthalten in Elsevier Science Zhang, Peng-Fang ELSEVIER Li-CO 2022 international journal of clinical chemistry and applied molecular biology Amsterdam [u.a.] (DE-627)ELV008356149 volume:474 year:2017 pages:88-95 extent:8 https://doi.org/10.1016/j.cca.2017.08.017 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 58.10 Verfahrenstechnik: Allgemeines VZ AR 474 2017 88-95 8 045F 540 |
allfieldsGer |
10.1016/j.cca.2017.08.017 doi GBV00000000000002.pica (DE-627)ELV020534698 (ELSEVIER)S0009-8981(17)30319-4 DE-627 ger DE-627 rakwb eng 540 610 540 DE-600 610 DE-600 660 VZ 660 VZ 58.10 bkl Yassaee, Vahid Reza verfasserin aut Clinical, biochemical and molecular features of Iranian families with mucopolysaccharidosis: A case series 2017transfer abstract 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier This study aims to ascertain the genetic variants which contribute to the most common types of MPS in eleven Iranian families. Clinical and biochemical features were obtained during initial examination and patients were further investigated for genetic defects in the MPS genes. Peripheral blood samples were obtained from all family members after obtaining written informed consent. Based on the patient's clinical diagnosis, three different genetic tests including Sanger sequencing of four genes (IDUA, IDS, SGSH, and GALNS), targeted panel (10 genes) and Whole Exome Sequencing (WES) techniques were applied to identify the causative variants. A total of 12 different mutations were identified in five genes, including nine novel mutations and three previously reported missense mutations. Sanger sequencing confirmation of the identified mutations determined one case of compound heterozygous in the NAGLU gene. This study aims to ascertain the genetic variants which contribute to the most common types of MPS in eleven Iranian families. Clinical and biochemical features were obtained during initial examination and patients were further investigated for genetic defects in the MPS genes. Peripheral blood samples were obtained from all family members after obtaining written informed consent. Based on the patient's clinical diagnosis, three different genetic tests including Sanger sequencing of four genes (IDUA, IDS, SGSH, and GALNS), targeted panel (10 genes) and Whole Exome Sequencing (WES) techniques were applied to identify the causative variants. A total of 12 different mutations were identified in five genes, including nine novel mutations and three previously reported missense mutations. Sanger sequencing confirmation of the identified mutations determined one case of compound heterozygous in the NAGLU gene. Hashemi-Gorji, Feyzollah oth Miryounesi, Mohammad oth Rezayi, Alireza oth Ravesh, Zeinab oth Yassaee, Fakhrolmolouk oth Salehpour, Shadab oth Enthalten in Elsevier Science Zhang, Peng-Fang ELSEVIER Li-CO 2022 international journal of clinical chemistry and applied molecular biology Amsterdam [u.a.] (DE-627)ELV008356149 volume:474 year:2017 pages:88-95 extent:8 https://doi.org/10.1016/j.cca.2017.08.017 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 58.10 Verfahrenstechnik: Allgemeines VZ AR 474 2017 88-95 8 045F 540 |
allfieldsSound |
10.1016/j.cca.2017.08.017 doi GBV00000000000002.pica (DE-627)ELV020534698 (ELSEVIER)S0009-8981(17)30319-4 DE-627 ger DE-627 rakwb eng 540 610 540 DE-600 610 DE-600 660 VZ 660 VZ 58.10 bkl Yassaee, Vahid Reza verfasserin aut Clinical, biochemical and molecular features of Iranian families with mucopolysaccharidosis: A case series 2017transfer abstract 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier This study aims to ascertain the genetic variants which contribute to the most common types of MPS in eleven Iranian families. Clinical and biochemical features were obtained during initial examination and patients were further investigated for genetic defects in the MPS genes. Peripheral blood samples were obtained from all family members after obtaining written informed consent. Based on the patient's clinical diagnosis, three different genetic tests including Sanger sequencing of four genes (IDUA, IDS, SGSH, and GALNS), targeted panel (10 genes) and Whole Exome Sequencing (WES) techniques were applied to identify the causative variants. A total of 12 different mutations were identified in five genes, including nine novel mutations and three previously reported missense mutations. Sanger sequencing confirmation of the identified mutations determined one case of compound heterozygous in the NAGLU gene. This study aims to ascertain the genetic variants which contribute to the most common types of MPS in eleven Iranian families. Clinical and biochemical features were obtained during initial examination and patients were further investigated for genetic defects in the MPS genes. Peripheral blood samples were obtained from all family members after obtaining written informed consent. Based on the patient's clinical diagnosis, three different genetic tests including Sanger sequencing of four genes (IDUA, IDS, SGSH, and GALNS), targeted panel (10 genes) and Whole Exome Sequencing (WES) techniques were applied to identify the causative variants. A total of 12 different mutations were identified in five genes, including nine novel mutations and three previously reported missense mutations. Sanger sequencing confirmation of the identified mutations determined one case of compound heterozygous in the NAGLU gene. Hashemi-Gorji, Feyzollah oth Miryounesi, Mohammad oth Rezayi, Alireza oth Ravesh, Zeinab oth Yassaee, Fakhrolmolouk oth Salehpour, Shadab oth Enthalten in Elsevier Science Zhang, Peng-Fang ELSEVIER Li-CO 2022 international journal of clinical chemistry and applied molecular biology Amsterdam [u.a.] (DE-627)ELV008356149 volume:474 year:2017 pages:88-95 extent:8 https://doi.org/10.1016/j.cca.2017.08.017 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 58.10 Verfahrenstechnik: Allgemeines VZ AR 474 2017 88-95 8 045F 540 |
language |
English |
source |
Enthalten in Li-CO Amsterdam [u.a.] volume:474 year:2017 pages:88-95 extent:8 |
sourceStr |
Enthalten in Li-CO Amsterdam [u.a.] volume:474 year:2017 pages:88-95 extent:8 |
format_phy_str_mv |
Article |
bklname |
Verfahrenstechnik: Allgemeines |
institution |
findex.gbv.de |
dewey-raw |
540 |
isfreeaccess_bool |
false |
container_title |
Li-CO |
authorswithroles_txt_mv |
Yassaee, Vahid Reza @@aut@@ Hashemi-Gorji, Feyzollah @@oth@@ Miryounesi, Mohammad @@oth@@ Rezayi, Alireza @@oth@@ Ravesh, Zeinab @@oth@@ Yassaee, Fakhrolmolouk @@oth@@ Salehpour, Shadab @@oth@@ |
publishDateDaySort_date |
2017-01-01T00:00:00Z |
hierarchy_top_id |
ELV008356149 |
dewey-sort |
3540 |
id |
ELV020534698 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV020534698</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230625132026.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2017 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.cca.2017.08.017</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000002.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV020534698</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0009-8981(17)30319-4</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">540</subfield><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">540</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">660</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">660</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">58.10</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Yassaee, Vahid Reza</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Clinical, biochemical and molecular features of Iranian families with mucopolysaccharidosis: A case series</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2017transfer abstract</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">8</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">This study aims to ascertain the genetic variants which contribute to the most common types of MPS in eleven Iranian families. Clinical and biochemical features were obtained during initial examination and patients were further investigated for genetic defects in the MPS genes. Peripheral blood samples were obtained from all family members after obtaining written informed consent. Based on the patient's clinical diagnosis, three different genetic tests including Sanger sequencing of four genes (IDUA, IDS, SGSH, and GALNS), targeted panel (10 genes) and Whole Exome Sequencing (WES) techniques were applied to identify the causative variants. A total of 12 different mutations were identified in five genes, including nine novel mutations and three previously reported missense mutations. Sanger sequencing confirmation of the identified mutations determined one case of compound heterozygous in the NAGLU gene.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">This study aims to ascertain the genetic variants which contribute to the most common types of MPS in eleven Iranian families. Clinical and biochemical features were obtained during initial examination and patients were further investigated for genetic defects in the MPS genes. Peripheral blood samples were obtained from all family members after obtaining written informed consent. Based on the patient's clinical diagnosis, three different genetic tests including Sanger sequencing of four genes (IDUA, IDS, SGSH, and GALNS), targeted panel (10 genes) and Whole Exome Sequencing (WES) techniques were applied to identify the causative variants. A total of 12 different mutations were identified in five genes, including nine novel mutations and three previously reported missense mutations. Sanger sequencing confirmation of the identified mutations determined one case of compound heterozygous in the NAGLU gene.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hashemi-Gorji, Feyzollah</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Miryounesi, Mohammad</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rezayi, Alireza</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ravesh, Zeinab</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yassaee, Fakhrolmolouk</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Salehpour, Shadab</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Zhang, Peng-Fang ELSEVIER</subfield><subfield code="t">Li-CO</subfield><subfield code="d">2022</subfield><subfield code="d">international journal of clinical chemistry and applied molecular biology</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV008356149</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:474</subfield><subfield code="g">year:2017</subfield><subfield code="g">pages:88-95</subfield><subfield code="g">extent:8</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.cca.2017.08.017</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">58.10</subfield><subfield code="j">Verfahrenstechnik: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">474</subfield><subfield code="j">2017</subfield><subfield code="h">88-95</subfield><subfield code="g">8</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">540</subfield></datafield></record></collection>
|
author |
Yassaee, Vahid Reza |
spellingShingle |
Yassaee, Vahid Reza ddc 540 ddc 610 ddc 660 bkl 58.10 Clinical, biochemical and molecular features of Iranian families with mucopolysaccharidosis: A case series |
authorStr |
Yassaee, Vahid Reza |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV008356149 |
format |
electronic Article |
dewey-ones |
540 - Chemistry & allied sciences 610 - Medicine & health 660 - Chemical engineering |
delete_txt_mv |
keep |
author_role |
aut |
collection |
elsevier |
remote_str |
true |
illustrated |
Not Illustrated |
topic_title |
540 610 540 DE-600 610 DE-600 660 VZ 58.10 bkl Clinical, biochemical and molecular features of Iranian families with mucopolysaccharidosis: A case series |
topic |
ddc 540 ddc 610 ddc 660 bkl 58.10 |
topic_unstemmed |
ddc 540 ddc 610 ddc 660 bkl 58.10 |
topic_browse |
ddc 540 ddc 610 ddc 660 bkl 58.10 |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
zu |
author2_variant |
f h g fhg m m mm a r ar z r zr f y fy s s ss |
hierarchy_parent_title |
Li-CO |
hierarchy_parent_id |
ELV008356149 |
dewey-tens |
540 - Chemistry 610 - Medicine & health 660 - Chemical engineering |
hierarchy_top_title |
Li-CO |
isfreeaccess_txt |
false |
familylinks_str_mv |
(DE-627)ELV008356149 |
title |
Clinical, biochemical and molecular features of Iranian families with mucopolysaccharidosis: A case series |
ctrlnum |
(DE-627)ELV020534698 (ELSEVIER)S0009-8981(17)30319-4 |
title_full |
Clinical, biochemical and molecular features of Iranian families with mucopolysaccharidosis: A case series |
author_sort |
Yassaee, Vahid Reza |
journal |
Li-CO |
journalStr |
Li-CO |
lang_code |
eng |
isOA_bool |
false |
dewey-hundreds |
500 - Science 600 - Technology |
recordtype |
marc |
publishDateSort |
2017 |
contenttype_str_mv |
zzz |
container_start_page |
88 |
author_browse |
Yassaee, Vahid Reza |
container_volume |
474 |
physical |
8 |
class |
540 610 540 DE-600 610 DE-600 660 VZ 58.10 bkl |
format_se |
Elektronische Aufsätze |
author-letter |
Yassaee, Vahid Reza |
doi_str_mv |
10.1016/j.cca.2017.08.017 |
dewey-full |
540 610 660 |
title_sort |
clinical, biochemical and molecular features of iranian families with mucopolysaccharidosis: a case series |
title_auth |
Clinical, biochemical and molecular features of Iranian families with mucopolysaccharidosis: A case series |
abstract |
This study aims to ascertain the genetic variants which contribute to the most common types of MPS in eleven Iranian families. Clinical and biochemical features were obtained during initial examination and patients were further investigated for genetic defects in the MPS genes. Peripheral blood samples were obtained from all family members after obtaining written informed consent. Based on the patient's clinical diagnosis, three different genetic tests including Sanger sequencing of four genes (IDUA, IDS, SGSH, and GALNS), targeted panel (10 genes) and Whole Exome Sequencing (WES) techniques were applied to identify the causative variants. A total of 12 different mutations were identified in five genes, including nine novel mutations and three previously reported missense mutations. Sanger sequencing confirmation of the identified mutations determined one case of compound heterozygous in the NAGLU gene. |
abstractGer |
This study aims to ascertain the genetic variants which contribute to the most common types of MPS in eleven Iranian families. Clinical and biochemical features were obtained during initial examination and patients were further investigated for genetic defects in the MPS genes. Peripheral blood samples were obtained from all family members after obtaining written informed consent. Based on the patient's clinical diagnosis, three different genetic tests including Sanger sequencing of four genes (IDUA, IDS, SGSH, and GALNS), targeted panel (10 genes) and Whole Exome Sequencing (WES) techniques were applied to identify the causative variants. A total of 12 different mutations were identified in five genes, including nine novel mutations and three previously reported missense mutations. Sanger sequencing confirmation of the identified mutations determined one case of compound heterozygous in the NAGLU gene. |
abstract_unstemmed |
This study aims to ascertain the genetic variants which contribute to the most common types of MPS in eleven Iranian families. Clinical and biochemical features were obtained during initial examination and patients were further investigated for genetic defects in the MPS genes. Peripheral blood samples were obtained from all family members after obtaining written informed consent. Based on the patient's clinical diagnosis, three different genetic tests including Sanger sequencing of four genes (IDUA, IDS, SGSH, and GALNS), targeted panel (10 genes) and Whole Exome Sequencing (WES) techniques were applied to identify the causative variants. A total of 12 different mutations were identified in five genes, including nine novel mutations and three previously reported missense mutations. Sanger sequencing confirmation of the identified mutations determined one case of compound heterozygous in the NAGLU gene. |
collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA |
title_short |
Clinical, biochemical and molecular features of Iranian families with mucopolysaccharidosis: A case series |
url |
https://doi.org/10.1016/j.cca.2017.08.017 |
remote_bool |
true |
author2 |
Hashemi-Gorji, Feyzollah Miryounesi, Mohammad Rezayi, Alireza Ravesh, Zeinab Yassaee, Fakhrolmolouk Salehpour, Shadab |
author2Str |
Hashemi-Gorji, Feyzollah Miryounesi, Mohammad Rezayi, Alireza Ravesh, Zeinab Yassaee, Fakhrolmolouk Salehpour, Shadab |
ppnlink |
ELV008356149 |
mediatype_str_mv |
z |
isOA_txt |
false |
hochschulschrift_bool |
false |
author2_role |
oth oth oth oth oth oth |
doi_str |
10.1016/j.cca.2017.08.017 |
up_date |
2024-07-06T17:52:04.921Z |
_version_ |
1803853050594459648 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV020534698</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230625132026.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2017 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.cca.2017.08.017</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000002.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV020534698</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0009-8981(17)30319-4</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">540</subfield><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">540</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">660</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">660</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">58.10</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Yassaee, Vahid Reza</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Clinical, biochemical and molecular features of Iranian families with mucopolysaccharidosis: A case series</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2017transfer abstract</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">8</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">This study aims to ascertain the genetic variants which contribute to the most common types of MPS in eleven Iranian families. Clinical and biochemical features were obtained during initial examination and patients were further investigated for genetic defects in the MPS genes. Peripheral blood samples were obtained from all family members after obtaining written informed consent. Based on the patient's clinical diagnosis, three different genetic tests including Sanger sequencing of four genes (IDUA, IDS, SGSH, and GALNS), targeted panel (10 genes) and Whole Exome Sequencing (WES) techniques were applied to identify the causative variants. A total of 12 different mutations were identified in five genes, including nine novel mutations and three previously reported missense mutations. Sanger sequencing confirmation of the identified mutations determined one case of compound heterozygous in the NAGLU gene.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">This study aims to ascertain the genetic variants which contribute to the most common types of MPS in eleven Iranian families. Clinical and biochemical features were obtained during initial examination and patients were further investigated for genetic defects in the MPS genes. Peripheral blood samples were obtained from all family members after obtaining written informed consent. Based on the patient's clinical diagnosis, three different genetic tests including Sanger sequencing of four genes (IDUA, IDS, SGSH, and GALNS), targeted panel (10 genes) and Whole Exome Sequencing (WES) techniques were applied to identify the causative variants. A total of 12 different mutations were identified in five genes, including nine novel mutations and three previously reported missense mutations. Sanger sequencing confirmation of the identified mutations determined one case of compound heterozygous in the NAGLU gene.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hashemi-Gorji, Feyzollah</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Miryounesi, Mohammad</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rezayi, Alireza</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ravesh, Zeinab</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yassaee, Fakhrolmolouk</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Salehpour, Shadab</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Zhang, Peng-Fang ELSEVIER</subfield><subfield code="t">Li-CO</subfield><subfield code="d">2022</subfield><subfield code="d">international journal of clinical chemistry and applied molecular biology</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV008356149</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:474</subfield><subfield code="g">year:2017</subfield><subfield code="g">pages:88-95</subfield><subfield code="g">extent:8</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.cca.2017.08.017</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">58.10</subfield><subfield code="j">Verfahrenstechnik: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">474</subfield><subfield code="j">2017</subfield><subfield code="h">88-95</subfield><subfield code="g">8</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">540</subfield></datafield></record></collection>
|
score |
7.3996735 |